Claims
- 1. A synthetic bioabsorbable drug-delivery material comprising:
a synthetic bioabsorbable polymeric matrix; an antibiotic phase dispersed into said polymeric matrix; and antibacterial, bioabsorbable, bioactive glass dispersed into said polymeric matrix for the promotion of bone growth.
- 2. The drug delivery material of claim 1, wherein the material is in the form of microspheres, spheres, capsules, tablets, pearls, pearls in string, beads, membranes, films, fibers, filaments, threads, cords or knitted or woven fiber fabrics.
- 3. The drug delivery material of claim 1, wherein said antibiotic phase comprises from 1 to 20 weight percent of said material.
- 4. The drug delivery material of claim 1, wherein at least a portion of said material is porous.
- 5. The drug delivery material of claim 4, wherein the surface of said material is porous.
- 6. The drug delivery material of claim 1, wherein said antibiotic phase is released from said material for a period of at least 4 weeks in in vivo conditions.
- 7. The drug delivery material of claim 6, wherein said bioactive glass is released from said material for a period of at least 4 weeks in in vivo conditions.
- 8. The drug delivery material of claim 6 wherein said antibiotic phase is released at a levelof at least 2 mg/l after 4 weeks in in vivo conditions.
- 9. The drug delivery material of claim 6 wherein said antibiotic phase is released at a level of at least 10 mg/l after 4 weeks in in vivo conditions.
- 10. The drug delivery material of claim 1 wherein said bioactive glass is in the form of fibers.
- 11. The drug delivery material of claim 10 wherein said fibers reinforce said material.
- 12. The drug delivery material of claim 1, wherein the material is self-reinforced through solid state deformation.
- 13. The drug delivery material of claim 9 wherein said antibiotic phase comprises ciprofloxazine.
- 14. A surgical implant comprising the material of claim 1.
- 15. The implant of claim 14, wherein the implant is in the form of a pin, screw, plate, tack, intramedullary nail, bolt, suture anchor, tissue anchor, interference screw, arrow, or wedge.
- 16. The implant of claim 14, wherein said material is a coating on the surface of said implant.
- 17. A method of treating osteomyelitis or bone infection in a bone comprising:
providing a synthetic bioabsorbable drug-delivery material comprising:
a synthetic bioabsorbable polymeric matrix; an antibiotic phase dispersed into said polymeric matrix; and antibacterial, bioabsorbable, bioactive glass dispersed into said polymeric matrix for the promotion of bone growth; and applying said material to said bone.
- 18. The method of claim 17 wherein said antibiotic phase comprises from 1 to 20 weight percent of said material and said antibiotic phase is released at a levelof at least 2 mg/l after 4 weeks in in vivo conditions.
Parent Case Info
[0001] This application is a continuation of U.S. patent application Ser. No. 09/410,288, filed Sep. 30, 1999, the disclosure of which is incorporated herein by reference.
Continuations (1)
|
Number |
Date |
Country |
Parent |
09410288 |
Sep 1999 |
US |
Child |
10320629 |
Dec 2002 |
US |